Danaher Corp

DHRNYSE · USD
229.91USD0.00 (-1.34%)
579

Danaher Corp (DHR) Option Chain

Danaher Corp trades at $229.91, down 1.34%, with an IV Rank of 44.25%. This is average versus the past year, and the company carries a market cap of $161,749M in the Diagnostics & Research industry. On the Nov 20, 2026 chain, the at the money $230.00 strike shows calls at $5.40 / $6.30 and puts at $2.15 / $4.00, both carrying about $4.42 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $237.50 calls, at 115 contracts, and the $230.00 puts, at 595, as of Nov 16, 2026.

Read more

Tracking the DHR option chain helps you see every strike and expiry on Danaher Corp in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DHR options activity at a glance. Use our scanner to monitor the DHR option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DHR stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where DHR options are being actively traded, and where they are not.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
19.6226954.744.918.7010.60225.00-3.440.602.200.001.401359780.38
27.9394005.092.417.008.00227.50-2.371.451.900.001.681827472.07
37.551,019525.850.005.406.30230.00-1.302.154.000.092.9859515162.46
47.895021103.900.002.904.90232.50-0.223.104.202.591.0619416752.11
58.27623603.880.002.755.00235.00+0.854.206.105.090.06348641.73

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryDiagnostics & Research
  • SectorHealthcare
  • IV Rank44.25% Moderate
  • Market cap (M$)161,749
  • 52 weeks high-5.31%
  • 52 weeks low42.86%
  • Analyst recommendationBuy
    1.52
  • Target price$260.43
    13.27% above the current stock price
  • Dividend—
  • Payout ratio25.36%
  • Earnings date2027-01-27
  • P/E37.65
  • Future P/E24.69
  • EPS (ttm)6.11
  • EPS growth next 5 years9.49%

As of Nov 16, 2026